Inhibits DGKγ, DGKδ, and DGKκ. Used to study DGKα role in lymphoproliferative diseases and XLP‐1 for instance. DGKα ED50 ∼18 μM. This evidence concerns the gene DGKA and X-linked lymphoproliferative disease.